{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T23:03:40Z","timestamp":1761951820586,"version":"build-2065373602"},"reference-count":73,"publisher":"Elsevier","isbn-type":[{"value":"9780443301223","type":"print"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/b978-0-443-30122-3.00007-8","type":"book-chapter","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T22:56:18Z","timestamp":1761951378000},"page":"513-534","source":"Crossref","is-referenced-by-count":0,"title":["Exploring the antidiabetic potential of chalcones through modulation of PTP1B and PPAR\u03b3"],"prefix":"10.1016","author":[{"given":"S\u00f3nia","family":"Rocha","sequence":"first","affiliation":[]},{"given":"Adelaide","family":"Sousa","sequence":"additional","affiliation":[]},{"given":"Rui","family":"Pereira","sequence":"additional","affiliation":[]},{"given":"Marisa","family":"Freitas","sequence":"additional","affiliation":[]},{"given":"Eduarda","family":"Fernandes","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/B978-0-443-30122-3.00007-8_bib0002","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/cbdd.14275","article-title":"A comprehensive review on the research progress of PTP1B inhibitors as antidiabetics","volume":"102","author":"Agrawal","year":"2023","journal-title":"Chemical Biology & Drug Design"},{"issue":"1","key":"10.1016\/B978-0-443-30122-3.00007-8_bib0003","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/S2213-8587(13)70187-6","article-title":"Diabetes: a look to the future","volume":"2","author":"Alberti","year":"2014","journal-title":"The Lancet Diabetes & Endocrinology"},{"issue":"Supplement_1","key":"10.1016\/B978-0-443-30122-3.00007-8_bib0001","first-page":"S20","article-title":"2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes - 2024","volume":"47","year":"2023","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/B978-0-443-30122-3.00007-8_bib0004","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1021\/acsmedchemlett.6b00301","article-title":"PPAR Agonists, Compounds, Pharmaceutical Compositions, and Methods of Use Thereof","volume":"7","author":"Blass","year":"2016","journal-title":"ACS Medicinal Chemistry Letters"},{"key":"10.1016\/B978-0-443-30122-3.00007-8_bib0005","series-title":"The Flavonoids","first-page":"442","article-title":"Chalcones, Aurones and Dihydrochalcones","author":"Bohm","year":"1975"},{"issue":"4","key":"10.1016\/B978-0-443-30122-3.00007-8_bib0006","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.3390\/ijms19041197","article-title":"PPAR Agonists and Metabolic Syndrome: An Established Role?","volume":"19","author":"Botta","year":"2018","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/B978-0-443-30122-3.00007-8_bib0007","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fendo.2017.00006","article-title":"Clinical Review of Antidiabetic Drugs: Implications for Type 2 Diabetes Mellitus Management","volume":"8","author":"Chaudhury","year":"2017","journal-title":"Frontiers in Endocrinology"},{"issue":"12","key":"10.1016\/B978-0-443-30122-3.00007-8_bib0008","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.3390\/molecules25122907","article-title":"The Antioxidant, Anti-Inflammatory, and Neuroprotective Properties of the Synthetic Chalcone Derivative AN07","volume":"25","author":"Chen","year":"2020","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/B978-0-443-30122-3.00007-8_bib0009","first-page":"297","article-title":"Peroxisome proliferator-activated receptor-gamma agonists and diabetes: current evidence and future perspectives","volume":"4","author":"Chiarelli","year":"2008","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/B978-0-443-30122-3.00007-8_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2020.154338","article-title":"The role of peroxisome proliferator-activated receptors (PPAR) in immune responses","volume":"114","author":"Christofides","year":"2021","journal-title":"Metabolism - Clinical and Experimental"},{"issue":"1","key":"10.1016\/B978-0-443-30122-3.00007-8_bib0059","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13205-022-03398-7","article-title":"Antibacterial potential of chalcones and its derivatives against Staphylococcus aureus","volume":"13","author":"da Silva","year":"2022","journal-title":"3 Biotech"},{"issue":"2","key":"10.1016\/B978-0-443-30122-3.00007-8_bib0011","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1517\/13543776.2012.661717","article-title":"Recent advances in the development of cinnamic-like derivatives as antituberculosis agents","volume":"22","author":"De","year":"2012","journal-title":"Expert Opinion on Therapeutic Patents"},{"issue":"1","key":"10.1016\/B978-0-443-30122-3.00007-8_bib0012","doi-asserted-by":"crossref","first-page":"15019","DOI":"10.1038\/nrdp.2015.19","article-title":"Type 2 diabetes mellitus","volume":"1","author":"DeFronzo","year":"2015","journal-title":"Nature Reviews Disease Primers"},{"issue":"6","key":"10.1016\/B978-0-443-30122-3.00007-8_bib0013","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/s41574-024-00965-1","article-title":"Protein tyrosine phosphatase 1B in metabolic diseases and drug development","volume":"20","author":"Delibegovi\u0107","year":"2024","journal-title":"Nature Reviews Endocrinology"},{"issue":"12","key":"10.1016\/B978-0-443-30122-3.00007-8_bib0014","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.2174\/0929867306666220401182509","article-title":"Bioactivities of Chalcones","volume":"6","author":"Dimmock","year":"1999","journal-title":"Current Medicinal Chemistry"},{"issue":"4","key":"10.1016\/B978-0-443-30122-3.00007-8_bib0015","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1080\/1061186X.2020.1853759","article-title":"A comprehensive review on the antiviral activities of chalcones","volume":"29","author":"Elkhalifa","year":"2021","journal-title":"Journal of Drug Targeting"},{"issue":"3","key":"10.1016\/B978-0-443-30122-3.00007-8_bib0016","doi-asserted-by":"crossref","first-page":"184","DOI":"10.2174\/2213337206666190306155140","article-title":"Recent Synthetic Methodologies for Chalcone Synthesis (2013-2018)","volume":"6","author":"Farooq","year":"2019","journal-title":"Current Organocatalysis"},{"issue":"9","key":"10.1016\/B978-0-443-30122-3.00007-8_bib0017","doi-asserted-by":"crossref","first-page":"728","DOI":"10.2174\/156802608784535084","article-title":"PPAR modulators and PPAR pan agonists for metabolic diseases: the next generation of drugs targeting peroxisome proliferator-activated receptors?","volume":"8","author":"Feldman","year":"2008","journal-title":"Curr Top Med Chem"},{"issue":"3","key":"10.1016\/B978-0-443-30122-3.00007-8_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.101030","article-title":"The therapeutic potential of inhibiting PPAR\u03b3 phosphorylation to treat type 2 diabetes","volume":"297","author":"Frkic","year":"2021","journal-title":"Journal of Biological Chemistry"},{"issue":"6","key":"10.1016\/B978-0-443-30122-3.00007-8_bib0019","doi-asserted-by":"crossref","first-page":"774","DOI":"10.3390\/plants9060774","article-title":"Flavonoids and Isoflavonoids Biosynthesis in the Model Legume Lotus japonicus; Connections to Nitrogen Metabolism and Photorespiration","volume":"9","author":"Garc\u00eda-Calder\u00f3n","year":"2020","journal-title":"Plants"},{"issue":"4","key":"10.1016\/B978-0-443-30122-3.00007-8_bib0020","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2174\/0929867053363153","article-title":"Chalcones: an update on cytotoxic and chemoprotective properties","volume":"12","author":"Go","year":"2005","journal-title":"Curr Med Chem"},{"issue":"9","key":"10.1016\/B978-0-443-30122-3.00007-8_bib0023","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1080\/13543776.2019.1655542","article-title":"Protein tyrosine phosphatase 1B (PTP1B) inhibitors as potential anti-diabetes agents: patent review (2015-2018)","volume":"29","author":"Hussain","year":"2019","journal-title":"Expert Opinion on Therapeutic Patents"},{"key":"10.1016\/B978-0-443-30122-3.00007-8_bib0024","unstructured":"International Diabetes Federation, IDF Diabetes Atlas, 10th edn. Brussels, Belgium: 2021. Available at: https:\/\/www.diabetesatlas.org."},{"issue":"1","key":"10.1016\/B978-0-443-30122-3.00007-8_bib0025","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2174\/157339907779802067","article-title":"Peroxisome proliferator-activated receptor (PPAR) in metabolic syndrome and type 2 diabetes mellitus","volume":"3","author":"Jay","year":"2007","journal-title":"Curr Diabetes Rev"},{"issue":"10","key":"10.1016\/B978-0-443-30122-3.00007-8_bib0026","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/aps.2012.90","article-title":"Natural products possessing protein tyrosine phosphatase 1B (PTP1B) inhibitory activity found in the last decades","volume":"33","author":"Jiang","year":"2012","journal-title":"Acta Pharmacologica Sinica"},{"key":"10.1016\/B978-0-443-30122-3.00007-8_bib0027","series-title":"Encyclopedia of Toxicology (Third Edition)","first-page":"815","article-title":"Peroxisome Proliferators","author":"Jiang","year":"2014"},{"issue":"9922","key":"10.1016\/B978-0-443-30122-3.00007-8_bib0028","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/S0140-6736(13)62154-6","article-title":"Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future","volume":"383","author":"Kahn","year":"2014","journal-title":"The Lancet"},{"key":"10.1016\/B978-0-443-30122-3.00007-8_bib0030","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.biopha.2018.10.196","article-title":"Preventive effect of trans-chalcone on non-alcoholic steatohepatitis: Improvement of hepatic lipid metabolism","volume":"109","author":"Karimi-Sales","year":"2019","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"10.1016\/B978-0-443-30122-3.00007-8_bib0032","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0265068","article-title":"Antitubercular activity assessment of fluorinated chalcones, 2-aminopyridine-3-carbonitrile and 2-amino-4H-pyran-3-carbonitrile derivatives: In vitro, molecular docking and in-silico drug likeliness studies","volume":"17","author":"Lagu","year":"2022","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/B978-0-443-30122-3.00007-8_bib0033","doi-asserted-by":"crossref","first-page":"4009","DOI":"10.3390\/molecules28104009","article-title":"Anticancer Activity of Chalcones and Its Derivatives: Review and In Silico Studies","volume":"28","author":"Leite","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/B978-0-443-30122-3.00007-8_bib0034","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.ejmech.2015.01.051","article-title":"Chalcones and their therapeutic targets for the management of diabetes: Structural and pharmacological perspectives","volume":"92","author":"Mahapatra","year":"2015","journal-title":"European Journal of Medicinal Chemistry"},{"key":"10.1016\/B978-0-443-30122-3.00007-8_bib0035","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ejmech.2015.05.004","article-title":"Anti-cancer chalcones: Structural and molecular target perspectives","volume":"98","author":"Mahapatra","year":"2015","journal-title":"European Journal of Medicinal Chemistry"},{"issue":"28","key":"10.1016\/B978-0-443-30122-3.00007-8_bib0029","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.2174\/1568026617666170914160446","article-title":"Chalcone Derivatives: Anti-inflammatory Potential and Molecular Targets Perspectives","volume":"17","author":"Mahapatra Kar","year":"2017","journal-title":"Current Topics in Medicinal Chemistry"},{"key":"10.1016\/B978-0-443-30122-3.00007-8_bib0036","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3389\/fphys.2019.00148","article-title":"The Central Role of Glucokinase in Glucose Homeostasis: A Perspective 50 Years After Demonstrating the Presence of the Enzyme in Islets of Langerhans","volume":"10","author":"Matschinsky","year":"2019","journal-title":"Frontiers in Physiology"},{"issue":"5-6","key":"10.1016\/B978-0-443-30122-3.00007-8_bib0037","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1080\/10715762.2022.2120396","article-title":"Recent advances in the antioxidant activity and mechanisms of chalcone derivatives: a computational review","volume":"56","author":"Mittal","year":"2022","journal-title":"Free Radical Research"},{"issue":"10","key":"10.1016\/B978-0-443-30122-3.00007-8_bib0021","doi-asserted-by":"crossref","first-page":"e20428","DOI":"10.1016\/j.heliyon.2023.e20428","article-title":"Antiviral and antimicrobial applications of chalcones and their derivatives: From nature to greener synthesis","volume":"9","author":"Nematollahi","year":"2023","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/B978-0-443-30122-3.00007-8_bib0038","doi-asserted-by":"crossref","first-page":"21781","DOI":"10.1038\/s41598-021-01292-5","article-title":"New chalcone derivatives as potential antimicrobial and antioxidant agent","volume":"11","author":"Okolo","year":"2021","journal-title":"Scientific Reports"},{"key":"10.1016\/B978-0-443-30122-3.00007-8_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.136258","article-title":"Structural and molecular insights of protein tyrosine phosphatase 1B (PTP1B) and its inhibitors as anti-diabetic agents","volume":"1293","author":"Paul","year":"2023","journal-title":"Journal of Molecular Structure"},{"key":"10.1016\/B978-0-443-30122-3.00007-8_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115280","article-title":"Bis-chalcones: A review of synthetic methodologies and anti-inflammatory effects","volume":"252","author":"Pereira","year":"2023","journal-title":"European Journal of Medicinal Chemistry"},{"issue":"43","key":"10.1016\/B978-0-443-30122-3.00007-8_bib0041","doi-asserted-by":"crossref","first-page":"38254","DOI":"10.1021\/acsomega.2c05518","article-title":"Chalcone Derivatives with a High Potential as Multifunctional Antioxidant Neuroprotectors","volume":"7","author":"P\u00e9rez-Gonz\u00e1lez","year":"2022","journal-title":"ACS Omega"},{"issue":"7","key":"10.1016\/B978-0-443-30122-3.00007-8_bib0042","doi-asserted-by":"crossref","first-page":"5273","DOI":"10.1007\/s11033-020-05605-1","article-title":"PPAR-Gamma as putative gene target involved in Butein mediated anti-diabetic effect","volume":"47","author":"Prabhu","year":"2020","journal-title":"Molecular Biology Reports"},{"issue":"15","key":"10.1016\/B978-0-443-30122-3.00007-8_bib0043","doi-asserted-by":"crossref","first-page":"4095","DOI":"10.1080\/10408398.2021.1872483","article-title":"A comprehensive review on the antidiabetic activity of flavonoids targeting PTP1B and DPP-4: a structure-activity relationship analysis","volume":"62","author":"Proen\u00e7a","year":"2022","journal-title":"Critical Reviews in Food Science and Nutrition"},{"key":"10.1016\/B978-0-443-30122-3.00007-8_bib0044","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112215","article-title":"Chalcone hybrids as privileged scaffolds in antimalarial drug discovery: A key review","volume":"193","author":"Qin","year":"2020","journal-title":"European Journal of Medicinal Chemistry"},{"key":"10.1016\/B978-0-443-30122-3.00007-8_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106786","article-title":"Roles of the peroxisome proliferator-activated receptors (PPARs) in the pathogenesis of nonalcoholic fatty liver disease (NAFLD)","volume":"192","author":"Qiu","year":"2023","journal-title":"Pharmacological Research"},{"issue":"5","key":"10.1016\/B978-0-443-30122-3.00007-8_bib0046","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2174\/138955706776876140","article-title":"Fine tuning of PPAR ligands for type 2 diabetes and metabolic syndrome","volume":"6","author":"Ramachandran","year":"2006","journal-title":"Mini Rev Med Chem"},{"key":"10.1016\/B978-0-443-30122-3.00007-8_bib0047","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103527","article-title":"Design, synthesis, docking and biological evaluation of chalcones as promising antidiabetic agents","volume":"95","author":"Rammohan","year":"2020","journal-title":"Bioorganic Chemistry"},{"issue":"11","key":"10.1016\/B978-0-443-30122-3.00007-8_bib0049","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nrd.2016.151","article-title":"Targeting hepatic glucose metabolism in the treatment of type 2 diabetes","volume":"15","author":"Rines","year":"2016","journal-title":"Nature Reviews Drug Discovery"},{"issue":"9","key":"10.1016\/B978-0-443-30122-3.00007-8_bib0053","doi-asserted-by":"crossref","first-page":"5510","DOI":"10.1039\/C9FO01298B","article-title":"A study towards drug discovery for the management of type 2 diabetes mellitus through inhibition of the carbohydrate-hydrolyzing enzymes \u03b1-amylase and \u03b1-glucosidase by chalcone derivatives","volume":"10","author":"Rocha","year":"2019","journal-title":"Food Funct"},{"issue":"14","key":"10.1016\/B978-0-443-30122-3.00007-8_bib0052","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.2174\/0929867325666181001112226","article-title":"A Systematic Review on Anti-diabetic Properties of Chalcones","volume":"27","author":"Rocha","year":"2020","journal-title":"Current Medicinal Chemistry"},{"key":"10.1016\/B978-0-443-30122-3.00007-8_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105604","article-title":"Nano-based drug delivery systems used as vehicles to enhance polyphenols therapeutic effect for diabetes mellitus treatment","volume":"169","author":"Rocha","year":"2021","journal-title":"Pharmacological Research"},{"key":"10.1016\/B978-0-443-30122-3.00007-8_bib0051","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.ijbiomac.2021.04.061","article-title":"Pyrazoles as novel protein tyrosine phosphatase 1B (PTP1B) inhibitors: An in vitro and in silico study","volume":"181","author":"Rocha","year":"2021","journal-title":"International Journal of Biological Macromolecules"},{"issue":"Volume 75, 2013","key":"10.1016\/B978-0-443-30122-3.00007-8_bib0054","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1146\/annurev-physiol-030212-183754","article-title":"Regulation of Insulin Secretion in Human Pancreatic Islets","volume":"75","author":"Rorsman","year":"2013","journal-title":"Annual Review of Physiology"},{"issue":"1","key":"10.1016\/B978-0-443-30122-3.00007-8_bib0055","doi-asserted-by":"crossref","first-page":"9046","DOI":"10.1038\/s41598-019-45178-z","article-title":"Combined obeticholic acid and elafibranor treatment promotes additive liver histological improvements in a diet-induced ob\/ob mouse model of biopsy-confirmed NASH","volume":"9","author":"Roth","year":"2019","journal-title":"Scientific Reports"},{"issue":"1","key":"10.1016\/B978-0-443-30122-3.00007-8_bib0056","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s11101-014-9387-8","article-title":"Naturally occurring chalcones and their biological activities","volume":"15","author":"Rozmer","year":"2016","journal-title":"Phytochemistry Reviews"},{"issue":"2","key":"10.1016\/B978-0-443-30122-3.00007-8_bib0031","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1002\/cber.18990320293","article-title":"Ueber die sechs isomeren Monooxybenzalacetophenone (Monooxychalkone)","volume":"32","author":"S. Kostanecki","year":"1899","journal-title":"Berichte der deutschen chemischen Gesellschaft"},{"issue":"2","key":"10.1016\/B978-0-443-30122-3.00007-8_bib0057","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2174\/092986712803414132","article-title":"Exploring Pharmacological Significance of Chalcone Scaffold: A Review","volume":"19","author":"Sahu","year":"2012","journal-title":"Current Medicinal Chemistry"},{"issue":"11","key":"10.1016\/B978-0-443-30122-3.00007-8_bib0058","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.2174\/0929867043365189","article-title":"Natural Medicine:The Genus Angelica","volume":"11","author":"Sarker","year":"2004","journal-title":"Current Medicinal Chemistry"},{"key":"10.1016\/B978-0-443-30122-3.00007-8_bib0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105626","article-title":"Recent updates on development of protein-tyrosine phosphatase 1B inhibitors for treatment of diabetes, obesity and related disorders","volume":"121","author":"Singh","year":"2022","journal-title":"Bioorganic Chemistry"},{"issue":"1","key":"10.1016\/B978-0-443-30122-3.00007-8_bib0061","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1186\/s12906-022-03777-w","article-title":"Antimalarial and immunomodulatory potential of chalcone derivatives in experimental model of malaria","volume":"22","author":"Sinha","year":"2022","journal-title":"BMC Complement Med Ther"},{"issue":"4","key":"10.1016\/B978-0-443-30122-3.00007-8_bib0062","first-page":"623","article-title":"[PPAR and diabetes]","volume":"63","author":"Terauchi","year":"2005","journal-title":"Nihon Rinsho"},{"issue":"1","key":"10.1016\/B978-0-443-30122-3.00007-8_bib0063","article-title":"Elafibranor Inhibits Chronic Kidney Disease Progression in NASH Mice","volume":"2019","author":"Tsai","year":"2019","journal-title":"BioMed Research International"},{"issue":"4","key":"10.1016\/B978-0-443-30122-3.00007-8_bib0064","doi-asserted-by":"crossref","first-page":"236","DOI":"10.4103\/2231-4040.90879","article-title":"The peroxisome proliferator-activated receptor: A family of nuclear receptors role in various diseases","volume":"2","author":"Tyagi","year":"2011","journal-title":"J Adv Pharm Technol Res"},{"key":"10.1016\/B978-0-443-30122-3.00007-8_bib0048","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.bioorg.2019.03.033","article-title":"Promising anti-inflammatory effects of chalcones via inhibition of cyclooxygenase, prostaglandin E2, inducible NO synthase and nuclear factor \u03bab activities","volume":"87","author":"ur Rashid","year":"2019","journal-title":"Bioorganic Chemistry"},{"issue":"1","key":"10.1016\/B978-0-443-30122-3.00007-8_bib0022","doi-asserted-by":"crossref","first-page":"5050","DOI":"10.1038\/s41598-021-83974-8","article-title":"Beneficial effects of elafibranor on NASH in E3L.CETP mice and differences between mice and men","volume":"11","author":"van den Hoek","year":"2021","journal-title":"Scientific Reports"},{"key":"10.1016\/B978-0-443-30122-3.00007-8_bib0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.fitote.2023.105596","article-title":"Synthesis and inhibitory activity of euparin derivatives as potential dual inhibitors against \u03b1-glucosidase and protein tyrosine phosphatase 1B (PTP1B)","volume":"169","author":"Wang","year":"2023","journal-title":"Fitoterapia"},{"key":"10.1016\/B978-0-443-30122-3.00007-8_bib0066","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103133","article-title":"Chalcone derivatives and their antibacterial activities: Current development","volume":"91","author":"Xu","year":"2019","journal-title":"Bioorganic Chemistry"},{"issue":"3","key":"10.1016\/B978-0-443-30122-3.00007-8_bib0067","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jep.2008.01.011","article-title":"Pharmacognostic and pharmacological profile of Humulus lupulus L.","volume":"116","author":"Zanoli","year":"2008","journal-title":"Journal of Ethnopharmacology"},{"issue":"6","key":"10.1016\/B978-0-443-30122-3.00007-8_bib0069","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.bmc.2019.01.034","article-title":"Synthesis, biological evaluation, and molecular docking study of novel allyl-retrochalcones as a new class of protein tyrosine phosphatase 1B inhibitors","volume":"27","author":"Zhao","year":"2019","journal-title":"Bioorganic & Medicinal Chemistry"},{"key":"10.1016\/B978-0-443-30122-3.00007-8_bib0068","doi-asserted-by":"crossref","DOI":"10.1016\/j.fitote.2022.105343","article-title":"Anti-hyperlipidemia on rats in vivo and new compounds from the seeds of Psoralea corylifolia","volume":"163","author":"Zhao","year":"2022","journal-title":"Fitoterapia"},{"issue":"2","key":"10.1016\/B978-0-443-30122-3.00007-8_bib0070","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nrendo.2017.151","article-title":"Global aetiology and epidemiology of type 2 diabetes mellitus and its complications","volume":"14","author":"Zheng","year":"2018","journal-title":"Nature Reviews Endocrinology"},{"issue":"7705","key":"10.1016\/B978-0-443-30122-3.00007-8_bib0071","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s41586-018-0088-0","article-title":"Pancreas regeneration","volume":"557","author":"Zhou","year":"2018","journal-title":"Nature"},{"issue":"2","key":"10.1016\/B978-0-443-30122-3.00007-8_bib0072","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1111\/cbdd.13319","article-title":"Design, synthesis chalcone derivatives as AdipoR agonist for type 2 diabetes","volume":"92","author":"Zhu","year":"2018","journal-title":"Chemical Biology & Drug Design"},{"issue":"12","key":"10.1016\/B978-0-443-30122-3.00007-8_bib0073","doi-asserted-by":"crossref","first-page":"7762","DOI":"10.1021\/acs.chemrev.7b00020","article-title":"Chalcone: A Privileged Structure in Medicinal Chemistry","volume":"117","author":"Zhuang","year":"2017","journal-title":"Chemical Reviews"}],"container-title":["Chalcones and their Derivatives"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780443301223000078?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780443301223000078?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T22:59:45Z","timestamp":1761951585000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780443301223000078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9780443301223"],"references-count":73,"URL":"https:\/\/doi.org\/10.1016\/b978-0-443-30122-3.00007-8","relation":{},"subject":[],"published":{"date-parts":[[2026]]}}}